Article Details

Repertoire Immune Medicines Secures $189M Financing to Advance Pipeline Programs and ...

Retrieved on: 2021-04-13 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

Repertoire Immune Medicines Secures $189M Financing to Advance Pipeline Programs and .... View article details on hiswai:

Excerpt

Repertoire Immune Medicines, a clinical-stage biotech company decoding the ... repertoire of T cell receptor-antigen pairs that drive cellular immunity.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo